Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 618 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Oral Supplement Clear all

Conditions: PreDiabetes
Interventions: Metformin, Placebo; Drug · Other
Lead sponsor: Diana Jalal; Other
Eligibility: 18 Years to 55 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Iowa City, Iowa

Conditions: Growth Disorders, Dietary Exposure, Child Development, Bone Development Abnormal, Body Weight, Child Malnutrition
Interventions: TruHeight Growth Protein Shake; Dietary Supplement
Lead sponsor: TruHeight Vitamins; Industry
Eligibility: 4 Years to 17 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Thyroid Disease, Kidney Diseases, Chronic
Interventions: Levothyroxine Sodium, Placebo Oral Tablet; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 75 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Orange, California

Conditions: Frailty, Functional Recovery, Prehabilitation
Interventions: Exercise, Nutrition, Meditation, Cognitive Behavioral Intervention; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Renal Failure, Coronary Artery Disease, Surgery, Surgery-Complications
Interventions: CoQ10 1200 mg orally with Glutathione 1000 mg orally, Group B: Placebo CoQ10 orally and Placebo Glutathione orally; Drug
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 242 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Healthy, Aging
Interventions: Shoden; Dietary Supplement
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 65 Years and older
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Healthy Volunteers
Interventions: Cardiosyn; Dietary Supplement
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Gastro-Intestinal Disorder
Interventions: Lysine butyrate, Sodium Butyrate, Tributyrin; Dietary Supplement
Lead sponsor: The Center for Applied Health Sciences, LLC; Industry
Eligibility: 25 Years to 45 Years · Male only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Canfield, Ohio

Conditions: Type 2 Diabetes
Interventions: Exenatide, Glargine, Rapid-acting insulin analogs; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Muscle Weakness
Interventions: mung bean protein, control biscuit; Dietary Supplement · Other
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Metastatic Colorectal Cancer
Interventions: Erlotinib, Fluorouracil, Leucovorin, Oxaliplatin, Irinotecan; Drug
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 80 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Age-Associated Memory Impairment
Interventions: Tricaprilin, Placebo; Drug · Other
Lead sponsor: Cerecin; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 6
States / cities: Brooksville, Florida • DeLand, Florida • Naples, Florida + 3 more

Conditions: Pregnancy
Interventions: Folic acid, 400 mcg/day, Folic acid 800 mcg/day; Dietary Supplement
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Diabetes
Interventions: Experimental Study Product, Control Study Product; Other
Lead sponsor: Abbott Nutrition; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 2
States / cities: Chicago, Illinois • Cincinnati, Ohio

Conditions: Stroke
Interventions: Ischemic Conditioning, Antioxidant Supplement; Device · Dietary Supplement
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Dysmenorrhea
Interventions: Chinese Herbal Medicine (CHM) supplement, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 36 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Lung Cancer
Interventions: vaccine 1650-G; Biological
Lead sponsor: Edward Hirschowitz; Other
Eligibility: 21 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Type 1 Diabetes Mellitus
Interventions: Allogeneic Pancreatic Islet Cells, Belatacept, Basiliximab, Mycophenolate Mofetil, Tacrolimus, Intraportal infusion of islet cells; Biological · Drug · Procedure
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Growth Hormone, Amino Acid
Interventions: Amino acid supplement, Placebo; Drug
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Ovarian Cancer, Epithelial Ovarian Cancer, Pancreatic Adenocarcinoma
Interventions: Prehabilitation; Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 65 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Dry Eye Syndrome
Interventions: Omega-3 fatty acid supplement, Placebo; Dietary Supplement
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Peyronie's Disease
Interventions: Vitamin D2, Vitamin E, Testosterone Pellets; Drug
Lead sponsor: Men's Health Boston; Other
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Chestnut Hill, Massachusetts

Conditions: Hypovitaminosis D, Hypovitaminosis
Interventions: Vitamin Arm 1, Vitamin Arm 2, Vitamin Arm 3, Placebo; Dietary Supplement · Other
Lead sponsor: Madigan Army Medical Center; Federal
Eligibility: 18 Years to 69 Years
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Human Microbiome
Interventions: Terminalia Chebula fruit extract, Placebo, Topical Terminalia Chebula, Topical Placebo; Dietary Supplement · Other
Lead sponsor: Integrative Skin Science and Research; Industry
Eligibility: 25 Years to 55 Years · Female only
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Sacramento, California

Search by objective public record fields.

Metformin and Vascular Function in Prediabetes

Evaluating the Effects of an Oral Protein Supplement on Children's Growth Patterns

A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients

Multi-Component Prehabilitation for Major Elective Surgery

Prevent Cardiac Surgery Associated AKI Trial

Ashwagandha Pharmacokinetics Study in Older Adults

Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis

A Pharmacokinetic Comparison of Three Butyrate Products

Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes

Effect of Supplementary Dietary Protein (21g Per Day) on Lean Mass and Strength in Sedentary, Adult Vegetarians

Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)

Tricaprilin In Age-Associated Memory Impairment

Folic Acid Supplementation in Pregnant Women: Dose Response

Evaluation of a Nutritional Product for People With Type 2 Diabetes

MitoQ and Ischemic Conditioning To Assess Vascular Health Outcomes

Chinese Herbal Medicine for Gynecologic Patients

Lung Cancer Vaccine Plus Oral Dietary Supplement

LEA29Y (Belatacept) Emory Edmonton Protocol

Single Low-Dose of Supplement Amino Acid

Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT

A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome

Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease

Evaluating Response to Vitamin D3 and K2 Supplementation in Healthcare Personnel

The Effects of Terminalia Chebula Fruit Extract on the Gut Microbiome and Skin Biophysical Properties